S odium nitroprusside (SNP)enhanced cardiopulmonary resuscitation (CPR), or SNPeCPR, is a new method of CPR. It consists of three components: 1) active compression-decompression CPR with an impedance threshold device (ACD CPRϩITD), which enhances active venous return, improves hemodynamics, and provides a superior method of thoracic compressions compared to standard CPR, as previously demonstrated in animal and randomized clinical trials (1-3); 2) large doses of intravenous SNP to decrease peripheral vascular resistance; and 3) lower abdominal binding that mechanically increases lower body resistance to descending aortic blood flow and effectively redistributes blood flow to the thorax and brain.
CO 2 (ETCO 2 ), rates of return to spontaneous circulation (ROSC), and 24-hr survival with good neurologic outcomes compared to standard CPR (S-CPR) (4) .
When VF is left untreated for Ͼ10 mins, the probability of successful ROSC decreases drastically (5) . Most reported animal experiments demonstrate minimal success in resuscitation rates after 10 -12 mins of untreated VF (6 -8) . Furthermore, it has been observed in many clinical trials that when CPR and resuscitation efforts are delayed Ͼ10 mins, short-and long-term resuscitation rates are extremely poor (1, 9) .
The effects of SNPeCPR on resuscitation rates after prolonged periods of untreated cardiac arrest have not been investigated. We hypothesized that: 1) SNPeCPR can significantly improve ROSC rates after 15 mins of untreated VF compared to S-CPR and ACD CPRϩITD; and 2) SNPeCPR will improve ROSC rates following a simulated period of bystander CPR in a pulseless electrical activity model of cardiac arrest.
MATERIALS AND METHODS
This study was approved by the Institutional Animal Care Committee of the Minneapolis Medical Research Foundation of Hennepin County Medical Center. All animal care was compliant with the National Research Council's 1996 Guidelines for the Care and Use of Laboratory Animals. All studies were performed by a qualified, experienced research team in Yorkshire female farm-bred pigs weighing 32 Ϯ 2 kg. A certified and licensed veterinarian assured the protocols were performed in accordance with the National Research Council's Guidelines.
Animals in both protocols had the same preparation.
Preparatory Phase
The surgical preparation, anesthesia, data monitoring, and recording procedures used in this study have been previously described (10) . Under aseptic surgical conditions, we used initial sedation with intramuscular ketamine (7 mL of 100 mg/mL, Ketaset, Fort Dodge Animal Health, Fort Dodge, IA) followed by inhaled isoflurane. A catheter (Mikro-Tip Transducer, Millar Instruments Houston, TX) was placed through a burr hole to enable real-time recording of intracranial pressure. Central aortic blood pressure was recorded continuously with the catheter placed in the descending thoracic aorta. A second Millar catheter was inserted in the right atrium via the right external jugular vein. An ultrasound flow probe (Transonic 420 series multichannel, Transonic Systems, Ithaca, NY) in the left common carotid artery was placed to quantify carotid blood flow (mL/min). All data were recorded with a digital recording system (Superscope II version 1.295, GW Instruments, Somerville, MA). Partial pressure of ETCO 2 , tidal volume, minute ventilation, and blood oxygen saturation were continuously measured with a respiratory monitor (CO 2 SMO Plus, Novametrix Medical Systems, Wallingford, CT).
Measurements and Recording
Aortic pressure, right atrial pressure, intracranial pressure, ETCO 2 , and carotid blood flow were continuously recorded. Coronary perfusion pressure was calculated from the difference between right atrial pressure and aortic pressure during the decompression phase of CPR. Cerebral perfusion pressure was calculated from the difference between the mean values of aortic pressure and intracranial pressure based on the recorded waveforms. Ultrasound-derived carotid blood flow was reported in mL/sec. ROSC was defined using the Utstein guidelines for uniform reporting in animal research (11) . Arterial blood gases were obtained at baseline, at 5-min CPR, and 30 mins following ROSC.
Experimental Protocol
Upon completion of the surgical preparation, VF was induced by delivering direct current via a temporary pacing wire (Daig Division, St. Jude Medical, Minnetonka, MN) positioned in the right ventricle. The ventilator was disconnected from the endotracheal tube. In each protocol, treatment assignment was randomized during the untreated VF period based on a computer-generated randomized list.
After 15 mins of untreated VF (protocol A) and 10 mins of VF (protocol B), closed-chest standard CPR (standard compression mode) was performed with a pneumatically driven automatic piston device (Pneumatic Compression Controller, Ambu International, Glostrup, Denmark) as previously described (12) . Uninterrupted chest compressions (100 compressions/min) with a 50% duty cycle and a compression depth of 25% of the anteroposterior chest diameter were provided. During CPR, asynchronous positive-pressure ventilations were delivered to simulate Advanced Life Support with a manual resuscitator bag (Smart Bag, O2 Systems, Toronto, Ontario, Canada). FIO 2 was 1.0, the tidal volume was maintained at ϳ10 mL/kg, and the respiratory rate was 10 breaths/min. Manual abdominal binding was added to provide approximately 50 lbs of force (upper body weight of one investigator leaning forward at a 45 degree angle as measured on a scale) to the lower half of the abdomen.
The investigators were blinded to hemodynamics during CPR. Blinding of ACD CPR and abdominal binding was not possible.
Protocol A
A total of 24 animals had untreated VF for 15 mins and were subsequently randomized to: 1) SNPeCPR (12 animals); or 2) S-CPR (six animals) (13); or 3) ACD CPRϩITD (six animals) (1) .
SNPeCPR Group. This group immediately received ACD CPRϩITD and abdominal binding as previously described (4) . In addition, animals received 2 mg of intravenous SNP at minute 1 of CPR, and 1 mg at minute 3 of CPR. The first defibrillation shock (150 J biphasic) was attempted at minute 6 of CPR. If after three shocks animals did not have successful ROSC, they received 0.015 mg/kg of epinephrine intravenously. If ROSC was not achieved within the next 2 mins, another dose of 1 mg SNP was administered and the above cycle was repeated (only two animals required epinephrine). CPR was continued for up to 15 mins at which point if there was no ROSC, the attempted resuscitation was terminated.
S-CPR Group. This group received S-CPR as recommended but the 2010 American Heart Association Guidelines with an advanced airway (14, 15) . Chest wall decompression was passive.
ACD CPRϩITD Group. The third group received ACD CPR with an ITD (ResQPOD Advanced Circulatory Systems, Roseville, MN) as previously described (16) .
The first dose of epinephrine (0.015 mg/kg) was given in the S-CPR and ACD CPRϩITD groups at minute 5 of CPR, and every 5 mins thereafter if ROSC was not achieved after the first three DC shocks.
All survivors were followed for 1 hr. A transthoracic echocardiogram was performed at that time to evaluate left ventricular ejection fraction from the right parasternal window (providing a similar view as the long and short parasternal windows for humans) (16) . Ejection fraction was assessed with trace planimetry and reported by a blinded echocardiographer unrelated to the study.
Intracardiac Echocardiographic Evaluation of Left Ventricular Dimensions During CPR. Twelve animals (six randomized to SNPeCPR and six to S-CPR) had an intracardiac ultrasound probe (Acuson Acunav diagnostic ultrasound catheter, Siemens, Washington DC) placed in the right ventricle and the left ventricle short-axis view centered at the mid papillary level obtained during the untreated VF period. After initiation of CPR and at minute 5, before the first DC shock, video images were collected and the diameters of the left ventricle cavity and septal wall were measured at the end of the decompression phase just before the initiation of the next compression cycle for three cycles. Measurements of the three cycles were averaged and were reported as the individual measurements for each animal. The end-diastolic (end of decompression) left ventricular cavity and septal wall dimensions were reported for each of the two primary interventions (SNPeCPR and S-CPR) as mean Ϯ SD.
Protocol B
Sixteen animals had 10 mins of untreated VF followed by 3 mins of chest compression only CPR (simulating bystander CPR). This was followed by a single 150 J DC shock at minute 3 of CPR to induce pulseless electrical activity (PEA) based on the model described in the study by Halperin et al (17) All animals developed PEA as documented by a 10-sec pause at minute 3 of CPR when central aortic pressure and echocardiogram were reviewed. Subsequently, animals were randomized into two groups: 1) S-CPR with 0.015 mg/kg epinephrine (eight controls) at minute 5 and then every 5 mins; and 2) SNPeCPR (eight animals) performed as in Protocol A (simulating an advanced cardiac life support intervention). CPR efforts were continued for up to 15 mins, and if ROSC was not achieved the study was terminated. Survivors were followed for 1 hr. If animals developed VF at any time during the CPR efforts, defibrillation was attempted. Animals with successful ROSC were followed for 1 hr.
Statistical Analysis
Values are expressed as mean Ϯ SD. Baseline data between groups were compared using the t test. Hemodynamics and blood gases during CPR were analyzed with single-factor analysis of variance for Protocol A and with nonpaired t test for protocol B. A two-tailed Fisher's exact test was used to compare ROSC rates. A p value of Ͻ .05 was considered statistically significant. Left ventricular dimensions were compared between the groups using a nonpaired t test.
RESULTS
There were no significant differences between baseline hemodynamic and blood gas characteristics in the animals that received SNPeCPR and the controls in either protocol.
Protocol A (15 mins of Untreated VF)
After 15 mins of untreated VF, SNPeCPR achieved ROSC in 12 of 12 animals, with an average of 2 Ϯ 1 shocks. S-CPR and ACD CPRϩITD with epinephrine were uniformly unsuccessful in achieving ROSC (0 of 6 and 0 of 6, respectively).
SNPeCPR significantly improved coronary perfusion pressure and carotid blood flow compared with both control groups. The carotid blood flow during CPR was similar to baseline carotid blood flow prearrest (Table 1 ).
Blood gases demonstrated less metabolic acidosis in the SNPeCPR groups 5 mins into CPR, and a normalization of pH and acidosis within 30 mins of ROSC. Additionally, ETCO 2 was significantly higher during CPR in the SNPeCPR group (Table 2) .
Intra-CPR Left Ventricular Dimensions. During SNPeCPR, the left ventricular end-of-decompression mid cavity diameter was significantly longer, and the septal wall was significantly thinner, than the S-CPR with epinephrine ( Fig. 1) .
Left Ventricular Ejection Fraction At 1 hr. In the SNPeCPR group, left ventricular function at 60 mins post-ROSC was low normal, with no wall motion abnormalities and an ejection fraction calculated as 52% Ϯ 9%.
Protocol B: (Countershockinduced PEA After 10 mins of Untreated VF and 3 mins of Chest Compression Only CPR)
SNPeCPR resulted in significant improvement in carotid blood flow and ETCO 2 compared to S-CPR with epinephrine when it was applied after chest compression only CPR ( Fig. 2A and B) . SNPeCPR resulted in a significant improvement in ROSC compared to S-CPR (7 of 8 vs. 0 of 8, p Ͻ .01) ( Table 3) .
Five animals that received SNPeCPR developed spontaneous electromechanical coupling that resulted in ROSC. The other two animals that had successful ROSC converted into course VF after 5 and 6 mins, respectively. VF was successfully shocked into sinus tachycardia In S-CPR animals, PEA degenerated into fine VF and asystole that was not amenable to DC shocks. Only two animals in the S-CPR had DC shocks attempted; both were unsuccessful.
Arterial blood gases showed significantly greater metabolic acidosis in the S-CPR group.
DISCUSSION
Our study, for the first time, has demonstrated that SNPeCPR has the ability to significantly improve resuscitation rates in two porcine models of prolonged, untreated cardiac arrest due to VF and countershock-induced PEA. S-CPR in the same settings was uniformly unsuccessful in restoring ROSC.
SNPeCPR provided superior hemodynamics and optimized forward blood flow (as evidenced by significantly increased carotid blood flow and ETCO 2 ) while also delivering higher vital organ perfusion pressures. Carotid blood flow was eightto ten-fold higher in the SNPeCPR group compared S-CPR with epinephrine in conjunction with higher coronary and cerebral perfusion pressures. The addition of a vasodilator in the setting of a very effective mechanical CPR platform led to a more than three-fold increase of ETCO 2 . This supports our initial contention that flow can be nearly normalized during CPR and can lead to significant improvement in resuscitation rates, even after prolonged untreated cardiac arrest.
We are unaware of any other clinically practical, noninvasive CPR method that could achieve consistent ROSC rates after 15 mins of untreated VF. SNPeCPR led to a significant improvement in hemodynamics when it was used as a simulated advanced cardiac life support intervention after chest compression only CPR and countershockinduced PEA. We hypothesize that large doses of SNP given during simulated advanced cardiac life support combined with mechanical adjuncts optimize vital organ perfusion pressures and redirect blood flow to the brain and thorax, significantly improving myocardial perfusion and facilitating spontaneous electromechanical coupling and ROSC. In two animals, PEA converted into very coarse VF that was successfully shocked into sinus tachycardia. Conversely, S-CPR animals that received epinephrine all degenerated after 5-7 mins into fine VF or asystole that was not amenable to successful defibrillation.
Contrary to the previous description by Kern et al (18) , we did not observe significant left ventricular dysfunction in the animals that received SNPeCPR in both protocols, despite similar or longer untreated cardiac arrest times. However, we did not have the ability to resuscitate any of the control animals. Exogenous nitric oxide donation has been shown to be protective from ischemia-reperfusion injury after prolonged arrest in transplanted hearts in a scenario similar to cardiac arrest, although in the present study, nitric oxide was not directly examined (19) .
We did identify a significantly larger left ventricular cavity and thinner walls when SNPeCPR was performed compared to S-CPR with epinephrine. This could be a direct effect of SNP or the effect of higher coronary perfusion. Regardless of the etiology of this observation, it is clear that much higher blood flow can be achieved through a larger, flaccid left ventricle compared to a smaller cavity with thicker, partially contracted walls. Ischemic contracture has been previously described during CPR and indicates a poor prognosis (20, 21) . Other investigators' efforts have focused on reducing ischemic contracture as a target to improve blood flow and outcomes during CPR (22, 23) . SNPeCPR appears to achieve improved left ventricular mechanics, however, the mechanism remains elusive.
Our study has several limitations. First, we did not assess neurologic function. A study on the effects of SNPeCPR on neurologic function has been completed and will be reported shortly. Second, although the rationale for implementing several interventions at one time is outlined in the introduction, this combination of interventions makes it difficult to assess each individual impact on the observed result. In our recent study, we demonstrated the need for SNP in addition to the mechanical platform to optimize neurologic function at 24 hrs (4) . Third, we cannot be certain that the results from our porcine model can be translated to humans. Finally, our models used open coronary arteries without stenosis, and therefore the applicability of SNPeCPR in an ischemic model of cardiac arrest needs to be further investigated. Values are Ϯ SD. Ten mins of untreated ventricular fibrillation followed by 3 mins of chest compression only CPR. All pressures in mm Hg, all flows in ml/min.
